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spot test method for the detection of piperazine
analogues in seized illicit materials
Morgan Philp,a Ronald Shimmon,a Natasha Stojanovska,a Mark Tahtouhb
and Shanlin Fu*a
The increasingly largequantitiesofpotentially illicit samples received forconﬁrmatoryanalysishighlights the
importance anddemand for preliminary testingprocedures that are simple, rapid, selective, inexpensive and
able to be used in the ﬁeld. Colour testing fulﬁls the aforementioned requirements and is a technique
frequently employed to achieve presumptive identiﬁcation. Piperazine analogues (often marketed as
‘legal ecstasy’) are a group of psychoactive substances that have recently become established on the illicit
drug market and are not eﬀectively discriminated or identiﬁed by current colour testing methods. Herein,
we report on the development and validation of a chemical spot test for piperazine analogues present in
unknown seized materials using the spectrophotometric reagent, sodium 1,2-naphthoquinone-4-
sulphonate (NQS). Primary testing revealed that NQS reacts almost instantly to form an intense, bright
orange-red coloured complex with the representative piperazine 1-benzylpiperazine (BZP) at room
temperature. The results of the test, assessed by colour development, were evaluated visually and
variables aﬀecting the coloured reaction were optimised. The colour test method was validated to meet
requirements for use in preliminary screening, providing qualitative and reliable presumptive test results.
Validation studies show that the characteristic colour change is unique to the piperazine class at room
temperature, and is unaﬀected by the presence of common cutting agents, i.e. glucose and caﬀeine, in
test samples of 5% purity, and other drugs such as N-methyl-3,4-methylenedioxyamphetamine (MDMA).
The NQS reagent stability was found to be limited to storage in a refrigerated environment for no more
than one week before results were aﬀected. The operational limit of detection was found to be 40 mg.1 Introduction
The most recent drug seizure data from the Australian Federal
Police (AFP) for the period 2010–2011 reported a 316% increase
in seized illicit drugs and precursors from the previous year.1
This statistic alone demonstrates the current prominent drug
situation in Australia, while gures provided by the United
Nations Oﬃce on Drugs and Crime (UNODC) highlight a similar
growth pattern globally.2
Synthetic piperazine analogues are newly established drugs
on the market that have seen a remarkable increase in abuse
worldwide owing to the ease of access aﬀorded by internet
availability.3 Piperazine analogues are central nervous system
stimulants and many possess hallucinogenic properties. They
are commonly used in combination with other piperazine
analogues or illicit substances including MDMA, cocaine or
ketamine.4istry and Forensic Science, University of
007, Australia. E-mail: Shanlin.Fu@uts.
514 8207
, Sydney, NSW 2000, Australia
5410A number of piperazine analogues are currently not under
international control. Many countries (including Australia) have
introduced national controls to prevent the sale and distribu-
tion of 1-benzylpiperazine (BZP) in particular.5 Following the
changing legal status of piperazine analogues, the number of
synthetic drugs being produced andmade available on the illicit
drug market predictably increased to include piperazines that
were not scheduled.6
Piperazine is a heterocyclic compound containing four
carbon atoms and two nitrogen atoms at the 1,4 position (also
called 1,4-hexahydropyrazine).7 Piperazine analogues can be
divided into two classes (Scheme 1): phenylpiperazines (1) and
benzylpiperazines (2). BZP is the most prevalent benzylpiper-
azine analogue while phenylpiperazine analogues include 1-[3-
(triuoromethyl)phenyl]piperazine (TFMPP), 1-(3-chlorophenyl)-
piperazine (mCPP), and 1-(4-methoxyphenyl)piperazine
(MeOPP).8
The conrmatory analysis of seized materials, and more
specically, piperazines, by techniques such as mass spec-
trometry (MS)9–12 and nuclear magnetic resonance (NMR)
spectroscopy11,12 is well documented in the literature. However,
due to the large amounts of unknown, seized materialsThis journal is ª The Royal Society of Chemistry 2013





























































































View Article Onlinereceived, conrmatory testing techniques can be time-
consuming and costly.
Preliminary testingof seizedmaterials is a vitalrst step in the
identication of potentially illicit drugs. These preliminary tests
combine techniques such as Fourier Transform Infrared spec-
troscopy (FTIR), Raman Spectroscopy and Thin Layer Chroma-
tography (TLC) with presumptive colour testing methods.
Presumptive colour tests are rapid, cheap, eﬀective and, in
contrast to FTIR and Raman, particularly useful in the detection
of target analytes within mixtures. They can also be specic,
require minimal sample preparation and able to be used by
untrained personnel given a sequence of steps and colour charts.
These colour tests are generally performed as chemical spot tests
on a small sample of the unknown material and evaluated visu-
ally in white, porcelain spotting well plates, or commercially
in polyethylene cartridges containing glass ampoules.
On-site analysis is becoming one of the most important
elds of modern analytical chemistry, while preliminary
screening in the laboratories is also becoming necessary due to
the increasing number of samples being submitted.
The requirements for colour testing have been described in
detail by Zolotov et al.13 These requirements include selectivity
toward the analyte to be determined, high contrast and rate of
colouring with the analyte, good reagent stability on storage,
and a suﬃciently stable analytical eﬀect.
The need for research into novel chemical testing procedures
governing piperazine analogues can be realised by looking at the
unsuccessful results aﬀorded by current preliminary testing
methods. The typical colour screening tests used for on-site eld
testing by frontline personnel are not able to be used reliably or
with any degree of specicity on piperazine analogues.9
The commonly encountered piperazine analogues BZP,
TFMPP, mCPP, pCPP and MeOPP each possess one cyclo
secondary amine functional group as part of their structure. For
the purpose of developing a test that will react with each of these
compounds, this secondary amine group is the likely target.
An estimation of amines using the spectrophotometric
reagent NQS has previously been described in the literature in
an ad-hoc manner.14–16 Dessouky and Ismaiel17 used the
formation of a red coloured product with NQS in the detection
of piperazine in pharmaceutical preparations. Supplementary
to this, Cabeza et al.18 studied the reaction between NQS and
primary or secondary amines in the presence of a non-ionic
surfactant with favourable results.This journal is ª The Royal Society of Chemistry 2013The literature contains no reports of NQS use in the detec-
tion of illicit piperazine analogues such as BZP. This work aims
to investigate, modify and develop the potential use of NQS as a
colour test reagent in the detection of piperazine analogues.
Method validation procedures were conducted for the proposed
colour test by considering the reaction with other drugs of
interest, reaction of common interferents, inherent sensitivity
of the method, stability of reagents and coloured products, and
the method's precision. The test exhibits excellent selectivity,
sensitivity and repeatability towards piperazine analogues.2 Experimental
2.1 Reagents and reference standards
Chemicals used in the development of a novel colour test
method were sodium 1,2-naphthoquinone-4-sulphonate (NQS)
and triton-X-100, both purchased from Sigma-Aldrich (Castle
Hill, NSW, Australia), and sodium hydrogen carbonate
(NaHCO3) and sodium hydroxide were supplied by Chem
Supply (Gillman, SA, Australia).
Working solutions of NQS at various concentrations were
freshly prepared each day and stored in the absence of light in a
refrigerator kept at 7 C while not being used. A 0.1% (v/v)
triton-X-100 working solution was also prepared. A NaHCO3
buﬀer solution was prepared by adjusting the pH of a 0.1 M
NaHCO3 solution to 10.8 with 5 M NaOH.
In addition to the synthesis of BZP and 4-methyl-
methcathinone (4-MMC) in house, a large number of certied
drug reference standards were obtained from the National
Measurement Institute (NMI, North Ryde, NSW, Australia)
through the AFP for a selectivity study. A list of these analytes
can be found in the selectivity results section.
Caﬀeine, ephedrine hydrochloride, codeine phosphate,
starch, glucose, sucrose and an extensive range of powdered
substances were obtained from Ajax Chemicals (Sydney, NSW,
Australia), BDH Chemicals (Sydney, NSW, Australia), Sigma
Chemical Company (Perth, WA, Australia), Glaxo Australia
(Sydney, NSW, Australia), Mallinckrodt (Lane Cove, NSW, Aus-
tralia), Chem-Supply and Sigma-Aldrich. Plain our, caster
sugar, protein powder and articial sweetener were from a local
supermarket. A full list of these chemicals analysed can be
found in the selectivity results section.
For colour tests on drugs in solution, working standard
solutions of BZP HCl and 4-MMC HCl were prepared at a
concentration of 500 mg mL1 in distilled water. Working
standard solutions of starch, glucose, caﬀeine, sucrose, codeine
and ephedrine HCl were prepared at a concentration of 1000 mg
mL1 in distilled water.2.2 Apparatus
Polypropylene at bottom 96-well microplates were obtained
from Greiner Bio-One and porcelain spotting well plates were
supplied by the AFP laboratory. A Simmerstat Plain Top 240V AC
from Industrial Equipment & Control Pty Ltd was used as the
hot plate during colour test procedures. All pH measurements
were carried out with a pH 211 Microprocessor from HANNAAnal. Methods, 2013, 5, 5402–5410 | 5403









6.4  103 M
1 0.5 mL 0.5 mL 0.5 mL 1.0 mL
2 1.0 mL 0.3 mL 0.2 mL 1.0 mL
3 1.0 mL 0.4 mL 0.1 mL 1.0 mL




























































































View Article Onlineinstruments. A digital CANON EFS 17-85 mm Single Lens Reex
(SLR) camera, DS126181, was employed to record all test results.
2.3 Preparation of BZP HCl and 4-MMC HCl
BZP HCl was synthesised following the method outlined by
Craig and Young.19 Equal molar piperazine hexahydrate and
piperazine dihydrochloride monohydrate were dissolved (to
form piperazine hydrochloride) in ethanol at 65 C and then
reacted with equal molar benzyl chloride for 25 minutes at
65 C. The reaction solution was cooled on ice and the pipera-
zine dihydrochloride monohydrate crystals were recovered by
ltration. The ltrate was cooled on ice and treated with etha-
nolic HCl. BZP HCl was collected as a white precipitate. Its
identity was conrmed by NMR,MS, and FTIR analysis. 1H NMR
(500 MHz, CDCl3): d 1.52 (1H, s), 2.41 (4H, t), 2.85 (4H, t), 3.49
(2H, s), 7.26 (5H, m) ppm. 13C NMR (125 MHz, CDCl3): d 46.12,
54.54, 63.68, 126.94, 128.13, 129.17, 138.10 ppm. Electron
impact MS: m/z 176 (M+, 16), 134 (60), 91 (100), 85 (10), 65 (14),
56 (23). IR nmax (cm
1): 3241, 2993, 2759, 1631, 1557, 1444, 1063.
4-MMC HCl was synthesised in two stages following a
modied method given by Camilleri et al.20 The rst a-bromi-
nation step involved reacting 4-methylpropiophenone with
excess bromine (to form 2-bromo-4-methylpropiophenone) in
the presence of glacial acetic acid at 25 C for 1 hour. The
reaction solution was poured into ice-cold water and the 2-
bromo-4-methylpropiophenone was extracted with dichloro-
methane and concentrated under vacuum to form yellow, uﬀy
crystals. The nal methamination step involved combining
equal molar NaOH and methylamine hydrochloride solutions.
This solution was then added dropwise over 1 hour to a stirred
solution of 2-bromo-4-methylpropiophenone in toluene. The
mixture was allowed to stir for 32 hours at 25 C and poured into
ice-cold water. The toluene layer was separated and acidied
with dilute HCl solution. The acidic extracts were washed with
toluene before evaporating the aqueous layer to dryness to
aﬀord the crude 4-MMC HCl product as mottled light brown/
brown coloured, aky crystals. A ne, white powder was
collected following recrystallisation from isopropanol. Its
identity was conrmed by NMR,MS, and FTIR analysis. 1H NMR
(500 MHz, D2O): d 1.62 (3H, d), 2.46 (3H, s), 2.82 (3H, s), 5.08
(1H, q), 7.47 (2H, d), 7.94 (2H, d) ppm. 13C NMR (125 MHz,
D2O): d 18.3, 23.8, 33.8, 62.4, 131.9, 132.6, 132.8, 150.3, 200.2
ppm. Electron impact MS:m/z 177 (M+, 2), 119 (6), 91 (12), 65 (8),
58 (100), 56 (8). IR nmax (cm
1): 2912, 2740, 2453, 1686, 1605.
2.4 Colour spot test method development
2.4.1 Description of the colours. A method described by
Cabeza et al.18 was adapted in this study. Colour changes were
described using the system adopted in Clarke's Analysis of
Drugs and Poisons.21 This system uses ten basic colours (red,
orange, yellow, green, blue, violet, together with pink, brown,
grey and black) with a variation in hue indicated by combining
two colours (e.g. orange-red). The second-named colour is
considered to be the dominant one.
2.4.2 Colour test in test tubes. Briey, to a glass culture
tube, in the order of addition, were added BZP HCl sample5404 | Anal. Methods, 2013, 5, 5402–5410(500 mg mL1), NaHCO3 buﬀer (pH 10.8), triton-X-100 (0.1%
(v/v)) and the NQS reagent working solution (6.4  103 M) up
to a total volume of 2.5 mL. The tube was then heated in a water
bath kept within a temperature range of 45–50 C for three
minutes. A control reagent blank, containing a distilled water
sample only, was tested simultaneously. Four preliminary
experiments were performed involving diﬀerent volumes of
sample and reagents as specied in Table 1. Colour changes
were observed and recorded before and aer heating.
2.4.3 Reduction to a small scale. The method was then
modied to be performed on a smaller scale in a plastic micro-
well plate using Pasteur pipettes to add drop-sized amounts of
reagents. To a plastic well were added BZP sample solution
(3 drops), NaHCO3 buﬀer (2 drops), triton-X-100 (1 drop) and
NQS (4 drops). The plate was le to stand for two minutes at
room temperature before being placed in a water bath set at 45–
50 C for three minutes. Colour changes were observed and
recorded before and aer heating.
Testing was performed on BZP HCl, 4-MMC HCl, ephedrine
HCl, codeine, caﬀeine, glucose, sucrose and starch sample
solutions alongside a control reagent blank.
2.4.4 Application to solid samples. A small pin-head sized
amount of each solid sample was placed in a well of a micro-well
plate. To this was added 5 drops of NaHCO3 buﬀer, with gentle
mixing for a few seconds, followed by 4 drops of NQS solution.
The plate was le to stand for two minutes at room temperature
and colour changes were observed and recorded.
2.5 Method validation
A series of tests were performed in order to determine the
method's reliability. These tests were chosen based on the
nature and purpose of the qualitative method.
2.5.1 Reproducibility. The general recommended colour
test procedure was applied to solid samples of pure BZP HCl.
The test was performed on ve replicate samples at the same
time. Further testing was completed in triplicate on the same
day with the same reagents in the same laboratory.
The developed test method was also performed in triplicate
on diﬀerent days, using diﬀerent reagents and in diﬀerent
laboratories and by diﬀerent operators. Certied reference
samples were tested in triplicate at the AFP laboratory both
intra-day and inter-day.
2.5.2 Selectivity/specicity. An extensive range of analytes
was collected to aid in the investigation of the selectivity and
specicity of the NQS colour test. These analytes included:
 Controlled drugs in the target group, i.e. piperazine
analogues.This journal is ª The Royal Society of Chemistry 2013
Fig. 1 Preliminary NQS colour testing performed in test tubes for reagent blank




























































































View Article Online Controlled drugs from other groups.
 Mixtures of piperazine analogues and other controlled
drugs.
 Common precursors to illicit drugs.
 Common diluents/excipients in the matrix of seized drugs.
Miscellaneous powdered substances and household tablets.
The drugs and other analytes were classied as drug stan-
dards, crystals, powders or tablets. Drug standards, crystals and
powders were tested without further processing, and tablets
were crushed into a ne powder using a mortar and pestle.
A small pin-head sized amount of each analyte to be tested
was added to the well of a porcelain spotting plate, or plastic
micro-well plate. The general recommended test procedure was
applied. The nal colours observed aer the required two
minutes standing time were recorded. Each analyte was tested
in triplicate.
2.5.3 Purity testing. A purity test was undertaken using
caﬀeine and glucose as cutting agents in samples of BZP HCl,
before application of the NQS test.
Methanolic solutions of BZP HCl at a concentration of
200 mg mL1 and methanolic solutions of caﬀeine and glucose
at 2000 mg mL1 were prepared.
Aliquots of 100 mL of the drug standard solution were
pipetted into eleven consecutive wells of a micro-well plate and
the solvent was allowed to evaporate under the fume hood. To
each of these wells was added, a specied aliquot of the meth-
anolic caﬀeine solution: 0, 2.5, 5, 10, 15, 20, 25, 32.5, 50, 65, 100
and 200 mL (0–95% (w/w) impurity). The solvent was again le to
evaporate. This was performed in triplicate. The developed NQS
colour test procedure was applied to each well. The resulting
colours were observed and recorded.
The process was repeated using the methanolic glucose
solution in place of the caﬀeine solution.
2.5.4 Limit of detection. The limit of detection was deter-
mined using a modied version of that recommended in the
National Institute of Justice's Colour Test Standard.22
A 200 mg mL1 methanolic solution of BZP HCl was
prepared. Five replicate aliquots of this solution of 0, 5, 10, 15,
20, 25, 30, 50, 100, 150, 200 and 250 mL were pipetted into a
micro well plate and the solvent was allowed to evaporate
under a fume hood. The general recommended test procedure
was applied. The colours were observed and recorded. The
lowest sample size producing a colour change noticeably
diﬀerent from that of the blank and characteristic for the
target analyte for all ve replicates was regarded as the limit of
detection.
A small survey was undertaken asking seven volunteers to
identify the sample size they considered to be the point at which
a noticeable colour change was apparent. This survey was con-
ducted over two days on two separate trials.
2.5.5 Robustness. The robustness and ruggedness of the
NQS colour test were examined through deliberate minor
changes made in the experimental condition, pH. Aliquots of
200 mL BZP HCl methanolic solutions were pipetted into 16 sets
of triplicate wells of a micro-plate, to deposit 40 mg of material
in each. NQS colour spot testing was performed on the BZP
samples and an adjacent blank well using a NaHCO3–NaOHThis journal is ª The Royal Society of Chemistry 2013buﬀer solution at 16 pH values ranging from 8.9 to 14.1. The
developed NQS colour test procedure was carried out, employ-
ing these prepared buﬀer solutions in place of the rst NaHCO3
reagent. Colours were observed and recorded.
2.5.6 Stability. An NQS reagent solution, prepared at a
concentration of 2.0  103 M, was divided into four separate
containers and these were allocated a diﬀerent storage
environment:
 Laboratory bench top
 Laboratory cupboard, covered in aluminium foil
 Refrigerator set at 7 C, covered in aluminium foil
 Digital water bath set at 35 C, sealed and covered in
aluminium foil
Each reagent solution was employed in the developed colour
testing procedure by applying to triplicate samples of the target
analyte, BZP HCl, alongside a blank reagent weekly for up to
three months. The colours produced in each test were observed
and recorded.3 Results and discussion
3.1 Colour spot test method development and optimisation
study
3.1.1 Colour test in test tubes. Primary testing aﬀorded
interesting results: the BZP sample produced an intense, bright
orange-red colour solution with a dark red precipitate at room
temperature almost immediately, notably diﬀerent from the
light yellow blank reagent test colour (see Fig. 1). The addition
of heat to the sample tube did not aﬀect the colour observed,
and similarly, variation of the reagent and sample ratios had no
eﬀect on the colour produced.
3.1.2 Reduction to a small scale. The use of drop sized
amounts of reagents in well-plates led to the colour changes
observed in the large scale method being successfully repli-
cated. The aqueous BZP HCl sample produced a bright, intense
orange-red colour solution almost immediately with a slow
forming red precipitate, whereas the control reagent blank
solution remained yellow (see Fig. 2).
3.1.3 Modication of reagents. The results showed that
variation of the triton-X-100 surfactant volume did not aﬀect the
hue of the colour produced by aqueous samples tested, or
the blank reagent. Triton-X-100 is a non-ionic surfactant used in
the coloured reaction as a solubilising agent. Given that the BZPAnal. Methods, 2013, 5, 5402–5410 | 5405
Fig. 2 Reduced scale NQS colour testing performed in plastic micro-well plates





























































































View Article Onlinereacted to form a highly coloured product with and without the
triton-X-100, it was removed from further testing procedures.
This would reduce the number of reagents, and associated costs
of employing the surfactant.
In contrast, results show that the reaction, and hence the
colour change will not take place without the addition of the
NaHCO3 buﬀer.
3.1.4 Application to solid samples. The method was
demonstrated to be eﬀective on solid samples. This testing also
provided preliminary validation of the specicity of the
proposed spot test method.
Seven common cutting agents, diluents and other white
powdered drugs tested did not react with the NQS at room
temperature, with the exception of ephedrine which reacted to
produce a yellow-orange colour. This was the only sample that
exhibited a possible interfering reaction; however, the colour
produced was distinctly diﬀerent from the orange-red product
resulting with solid BZP HCl.
3.1.5 Eﬀect of the NQS concentration. Five dilute solutions
of NQS were prepared at concentrations of 3.0  103 M, 2.5 
103 M, 2.0  103 M, 1.5  103 M and 1.0  103 M via
serial dilution. The spot test method was applied to a control
blank well, and pin-head sized amounts of ephedrine HCl, BZP
HCl and 4-MMC HCl using each dilute NQS concentration.
This study revealed that the reaction was to some extent
dependent on the reagent concentration: i.e. an increase in
intensity of the observed colour with the increasing NQS
concentration.
The NQS concentration at 2.0  103 M was chosen as the
optimal concentration to aﬀord an intense orange-red coloured
product with BZP HCl, and a pale, light yellow coloured product
with the reagent blank.3.2 General recommended procedure
Optimum working conditions were selected by considering the
inuence of reaction parameters such as reaction time, pH,
NQS concentration and temperature. Reaction times were
selected based on general observations in order to provide for
consistent results amongst tests.
To a pin head sized amount of unknown powder sample:
1. Add 5 drops of 0.1 M NaHCO3–NaOH buﬀer solution,
ensuring adequate mixing for a few seconds,
2. Followed by addition of 4 drops of 2.0  103 M NQS
solution, and
3. Record the colour change aer 2 minutes.5406 | Anal. Methods, 2013, 5, 5402–54103.3 Evaluation of validation data
3.3.1 Reproducibility. The repeatability of the method was
determined by testing samples on the same day with the same
reagents in the same laboratory. The identical colour results of
these analyses demonstrate the repeatability of the proposed
methods.
The reproducibility was determined by varying the condi-
tions of testing. The test performance on diﬀerent days, using
diﬀerent reagents and even in diﬀerent laboratories with
diﬀerent heating apparatus and well plates showed no eﬀect on
the NQS colour test results, thus warranting the reproducibility
of this method.
3.3.2 Selectivity/specicity. The UNODC recommends a
minimum of 20 test samples for selectivity analyses. In this
study over 90 substances were examined. The list of substances
subjected to the NQS test can be found in Tables 2 and 3.
The selectivity of a colour test used in the preliminary
identication of drugs is particularly important, as interfer-
ences from substances other than the analyte of interest may
lead to false positives. Ideally, the NQS will only react with
piperazine analogues, i.e. it is selective to piperazine analogues.
The application of the procedure to seven discrete aqueous
samples of diluents, excipients and other drugs at room
temperature showed no colour change from the reagent blank
and therefore no reaction occurred within the two minute
standing period. The potential of NQS as a colour test reagent
for BZP specically was realised.
The addition of heat, with a controlled water bath, to the
colour testing of these particular substances had no eﬀect on
the reactions of starch, glucose, caﬀeine, sucrose and codeine
which did not react and showed the same yellow colour as the
reagent blank. Ephedrine and 4-MMC, however, reacted to
produce a colour change of red-brown and brown, respectively
(see Fig. 3). It should be noted that during heating, ephedrine
initially produced a colour change to orange-yellow which
subsequently darkened within a short time. The positive reac-
tions with other substances allow for the potential application
of the NQS reagent in their detection. It was decided to omit the
heating stage and keep the reaction standing time as two
minutes for testing in future in order to increase the selectivity.
The NQS reagent was found to produce an incredibly bright
orange-red colour complex specic to BZP only. The ve other
piperazine analogues tested, TFMPP, mCPP, pCPP, MeOPP and
piperazine, also produced orange-red colour. The results of BZP,
TFMPP and mCPP alongside a reagent control blank can be
seen in Fig. 4. Although not obvious in the image, the apparent
brilliance of BZP made it distinguishable from the others upon
visual examination.
The bright, intense orange-red colour exhibited by the piper-
azine analogues was not produced by other analytes tested. This
result ishighlydesirable foranycolour test reagentas it shows the
highly selective nature of the colour test. In addition, the speci-
city of theNQS colour test toward the single analyte, BZP, is also
apparent by the uniquely bright colour as the result.
No common cutting agent, excipient or diluent was found to
react with the NQS reagent at room temperature. This is aThis journal is ª The Royal Society of Chemistry 2013
Table 2 Results of the NQS colour test against six common piperazines, and a
range of amphetamines, common precursor chemicals and other recreational
drugs
Sample analyte Spot test coloura




1-(3-Chlorophenyl)piperazine (mCPP) HCl Orange-red
1-(4-Chlorophenyl)piperazine (pCPP) HCl Orange-red






phenyl]glycidic acid methyl ester
NR













Amphetamine sulphate Light orange-yellow
(+/)-Methamphetamine HCl Light pink-orange
Gamma-hydroxy butyrate NR









































Table 2 (Contd. )
Sample analyte Spot test coloura
3-Fluoromethcathinone NR
Ethylcathinone NR






a NR describes a spot test whereby no reaction occurred and therefore
no change in colour was observed.




























































































View Article Onlinesignicant and important factor that can determine the prac-
ticality of a colour test when used for the purpose of identi-
cation of unknown solid sample mixtures. Two further tests
involving multiple control substances were performed: a BZP
and TFMPP mixed solid sample, and a BZP and MDMA solid
mixture. Both of these samples turned to an orange-red colour,
testing positive for the presence of piperazine and thus showing
the potential for application of the test in case work.Table 3 Results of the NQS colour test against common adulterants, excipients
and other powdered substances






























Protein powder Dark yellow
Self raising our/plain our NR
a NR describes a spot test whereby no reaction occurred and therefore
no change in colour was observed.
Anal. Methods, 2013, 5, 5402–5410 | 5407
Fig. 3 Small scale NQS colour testing with addition of heat performed in plastic
micro-well plates on a blank control reagent (a), BZP HCl (b), ephedrine HCl (c),
and 4-MMC HCl (d) sample solutions.
Fig. 4 Selectivity results performed in white glazed porcelain spotting plates on
blank control reagent (a) and piperazine analogues: BZP HCl (b), TFMPP HCl (c)




























































































View Article OnlineA number of non-piperazine compounds reacted with the
NQS reagent at room temperature to aﬀord a range of dull
colours. This diﬀerence in colour between reacting amines
could be explained by the location of the amine group in
piperazine analogues being in a cyclo group.
The NQS is known to react with the amino group of target
analytes. As a result, the interference of endogenous amines
remains a concern.
3.3.3 Purity testing. The purity testing showed that with an
impurity present in the sample at known concentrations
ranging from 0% (w/w) to 95% (w/w), there is no obvious eﬀect
on the colour reaction taking place with NQS. Caﬀeine and
glucose cut samples both appeared unaﬀected upon visual
examination with the naked eye. The samples cut with excipi-
ents provided the requisite bright orange-red colour at all purity
percentages (0–95% (w/w)) aer two minutes. However, it was
noticed that caﬀeine cut samples took longer to develop the
required colour: ranging from less than 90 seconds for 0% w/w
impurity to two minutes for 95% (w/w) impurity.
A given common sample matrix may contain endogenous or
exogenous interfering substances, purity testing is carried out
to determine the eﬀects that these interfering substances have
on the colour produced. Purity data for piperazine analogues in
seized materials is not available in the Australian Crime Com-
mission's latest Illicit Drug Data Report, nor can they be found
in the UNODC's World Drug Report 2012.Fig. 5 Results of limit of detection testing of BZP HCl using the NQS colour test met
20, 30, 40 and 50 mg, respectively.
5408 | Anal. Methods, 2013, 5, 5402–54103.3.4 Limit of detection. The limit of detection was deter-
mined by approaching the concentration where no change in
colour could easily be determined in reference to a blank
sample. Cut-oﬀ values were set at the lowest concentration
tested which unmistakably resulted in a colour change as rec-
ommended by the SWGDRUG.23 The amounts of each target
compound analysed were 1, 2, 3, 4, 5, 6, 10, 20, 30, 40 and 50 mg,
alongside a control blank containing 0 mg for comparison
purposes. The results of testing for BZP using the NQS reagent
are provided in Fig. 5.
The lowest concentration of BZP that aﬀorded a colour
change distinguishable from the background noise was deter-
mined to be 4 mg. This concentration was thenmultiplied by ten
and recorded as the ‘operational drug detection limit’ at 40 mg.
It should be noted that LOD is not a particularly robust
parameter andmay be aﬀected by minor changes in operational
conditions. In addition, the subjective nature of the determi-
nation of the detection limit adds further room for inadequa-
cies. In an attempt to add further validity to the proposed limits
of detection, seven random participants were asked their
opinion as to which concentration aﬀorded the lowest detect-
able colour change. The results were in unanimous agreement
with the proposed limits of detection.
For comparative purposes, the LOD of D-amphetamine HCl
and D-methamphetamine HCl using the well established
Marquis reagent is 20 mg and 100 mg, respectively.22 It follows
that these determined limits are well within an acceptable range
for use as colour test reagents.
3.3.5 Robustness. The UNODC denes robustness as the
ability of a method to remain unaﬀected by small but deliberate
variations in the main parameters of the method. It provides
reliability to a method during its normal usage for assessment.
Ruggedness is the ability to withstand small uncontrolled or
unintentional changes in operating conditions and assesses the
reproducibility of results obtained by analysis of the same
samples under a variety of conditions.
The results of robustness testing on NQS showed that at each
tested pH, with the exception of pH 14.1, the desired coloured
product was observed. The time taken for development of this
colour, however, varied. In the pH range of 9.0–11.0 the
appropriate colour changes were developed within two minutes
at room temperature, with the optimum pH level towards the
end of the range. While between pH 11.1–13.3 the development
time took from three minutes to six minutes. It was evident that
the test method was signicantly robust in regards to slight
variations in pH.
3.3.6 Stability. The stability of the NQS reagent was
demonstrated in this validation by comparing reagents freshlyhod performed in plastic micro-well plates. Amounts used are 0, 1, 2, 4, 5, 7, 9, 10,
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View Article Onlineprepared with those of equal concentration that have been
retained for diﬀerent periods of time under various storage
conditions.
The NQS reagent showed limited stability in regards to
storage conditions and consequently, the storage time period.
The NQS reagent has a light yellow colour when freshly
prepared. Following storage in the 35 C water bath for one
week, the reagent itself turned to an intense brown colour and
thus failed to produce coloured reactions with the target ana-
lytes. Similarly, the stored laboratory bench top and cupboard
reagents developed dark brown precipitates aer one month.
Aer three weeks of storage in a refrigerator, the reagent had a
dark orange colour and was no longer suitable for further
monitoring. Colour tests were performed weekly on samples
and control reagent blanks until the solution was considered
unusable based on resulting colour changes.
The application of NQS as a colour test reagent would require
the preparation of fresh test solutions weekly or just prior to use
and be stored covered in the refrigerator in the meantime. This
is not an ideal situation, however, preparation of this aqueous
solution is considerably easy using distilled water only.
The stability of the BZP-NQS coloured product was demon-
strated by examining the spotting well aer a 24 hour standing
period. The BZP-NQS complex remained slightly coloured and a
red coloured precipitate crashed out of solution.3.4 Proposed reaction mechanism
The inuences of pH can be understood by investigation of the
reaction mechanism involved. The buﬀer solution employed is
alkaline to provide the means for turning the protonated amine
salt (–NH2
+) into an amino group (–NH). In general, a higher pH
will more eﬀectively remove this proton.
The reaction of the primary amine salt, amantadine hydro-
chloride, in alkaline medium with NQS was described by
Mahmoud. et al.15 In their proposed mechanism, the sulpho-
nate group of the NQS is replaced by the amino group of the
amine. This nucleophilic substitution reaction has also been
proposed by Ali and Elbashir16 in their validated method for
determining olanzapine using NQS at pH 13.
The eﬀect of temperature on the reaction of NQS with BZP
was studied by carrying out the reaction at diﬀerent tempera-
tures (25 C–85 C). It was found that the reaction of BZP with
NQS was not aﬀected by the increasing temperature; no changes
in the coloured product were observed upon heating. The
reaction at room temperature went to completion in two
minutes. Application of the test to samples other than BZP ledThis journal is ª The Royal Society of Chemistry 2013to the increase of reaction time to eight minutes at 85 C to
provide for a wider range of coloured reactions.
The chemical structure of the coloured product formed upon
reaction between NQS and BZP has been proposed in Scheme 2.
Similarly, the amino groups of those substances aﬀording a
colour change with the NQS test will be the functional group
involved in the reaction. Thehighly coloured complexesproduced
through reaction with NQS are the result of a high degree of
conjugation aﬀorded in the newly prepared molecule. Full struc-
tural elucidation of the product is of interest for future studies.
4 Conclusions
Preliminary investigation on the use of NQS as a colour test
reagent for piperazine analogues revealed that there exists great
potential for further application. A bright, orange-red product
formed during the reaction of NQS with BZP is not only
distinctly diﬀerent from the light yellow coloured reagent blank,
but selectivity tests show that this characteristic colour change
and colour intensity did not match with any other substance
tested.
The proposed colour test procedure fullls laboratory
screening colour test requirements, using small quantities of
non-toxic reagents on limited amounts of solid samples,
resulting in a characteristic colour change to orange-red within
two minutes at room temperature in the presence of the
piperazine analogues.
The suitability of NQS as a novel colour testing reagent for
the purpose of preliminary detection of piperazine analogues
was eﬀectively evaluated through the examination of method
validation parameters. The excellent selectivity of the NQS
colour test toward piperazine analogues, combined with the
lack of interference from the majority of analytes tested and its
superior reproducibility, aﬀords the reagent great potential for
exploitation as a colour test reagent. The addition of heat
provides the test with an even greater scope for identication of
other reacting analytes. The results of the investigation allow for
suggested additions to current preliminary testing workows.
Future work would involve NQS reagent stability studies to
investigate the means of suppressing the instability of the
reagent without aﬀecting its use as a colour test reagent. This
would allow for its use in eld testing kits.
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